• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆汁酸作为代谢紊乱生物标志物的潜力。

The Potential of Bile Acids as Biomarkers for Metabolic Disorders.

机构信息

State Key Laboratory of Animal Nutrition and Feeding, Institute of Animal Science, Chinese Academy of Agricultural Sciences, Beijing 100193, China.

出版信息

Int J Mol Sci. 2023 Jul 28;24(15):12123. doi: 10.3390/ijms241512123.

DOI:10.3390/ijms241512123
PMID:37569498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10418921/
Abstract

Bile acids (BAs) are well known to facilitate the absorption of dietary fat and fat-soluble molecules. These unique steroids also function by binding to the ubiquitous cell membranes and nuclear receptors. As chemical signals in gut-liver axis, the presence of metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus (T2DM), and even tumors have been reported to be closely related to abnormal levels of BAs in the blood and fecal metabolites of patients. Thus, the gut microbiota interacting with BAs and altering BA metabolism are critical in the pathogenesis of numerous chronic diseases. This review intends to summarize the mechanistic links between metabolic disorders and BAs in gut-liver axis, and such stage-specific BA perturbation patterns may provide clues for developing new auxiliary diagnostic means.

摘要

胆汁酸(BAs)是众所周知的促进膳食脂肪和脂溶性分子的吸收。这些独特的甾体还通过与无处不在的细胞膜和核受体结合来发挥作用。作为肠肝轴的化学信号,存在代谢紊乱,如非酒精性脂肪性肝病(NAFLD)、2 型糖尿病(T2DM),甚至肿瘤,据报道与患者血液和粪便代谢物中 BAs 的异常水平密切相关。因此,与 BAs 相互作用并改变 BA 代谢的肠道微生物群在许多慢性疾病的发病机制中至关重要。本综述旨在总结肠肝轴中代谢紊乱与 BAs 之间的机制联系,这种特定阶段的 BA 扰动模式可能为开发新的辅助诊断手段提供线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/c5dd2a9b57b3/ijms-24-12123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/42b693d7110f/ijms-24-12123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/42980ef298ae/ijms-24-12123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/0f80761ceb62/ijms-24-12123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/c5dd2a9b57b3/ijms-24-12123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/42b693d7110f/ijms-24-12123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/42980ef298ae/ijms-24-12123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/0f80761ceb62/ijms-24-12123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da34/10418921/c5dd2a9b57b3/ijms-24-12123-g004.jpg

相似文献

1
The Potential of Bile Acids as Biomarkers for Metabolic Disorders.胆汁酸作为代谢紊乱生物标志物的潜力。
Int J Mol Sci. 2023 Jul 28;24(15):12123. doi: 10.3390/ijms241512123.
2
Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non-alcoholic fatty liver disease.体育锻炼在重新平衡非酒精性脂肪性肝病的肠肝轴胆汁酸中发挥作用。
Acta Physiol (Oxf). 2024 Jan;240(1):e14065. doi: 10.1111/apha.14065. Epub 2023 Dec 1.
3
Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease.胆汁酸受体与非酒精性脂肪性肝病的肠-肝轴。
Cells. 2021 Oct 20;10(11):2806. doi: 10.3390/cells10112806.
4
The chronic consumption of dietary fructose promotes the gut Clostridium species imbalance and bile acid alterations in developing nonalcoholic fatty liver disease.慢性摄入膳食果糖会促进肠道梭菌属物种失衡和胆汁酸改变,从而导致非酒精性脂肪性肝病的发生。
J Nutr Biochem. 2023 Nov;121:109434. doi: 10.1016/j.jnutbio.2023.109434. Epub 2023 Sep 1.
5
Role of Bile Acids in Metabolic Control.胆汁酸在代谢控制中的作用。
Trends Endocrinol Metab. 2018 Jan;29(1):31-41. doi: 10.1016/j.tem.2017.11.002. Epub 2017 Nov 28.
6
Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.蒺藜草提取物通过调节肠道微生物群和胆汁酸代谢减轻小鼠非酒精性脂肪性肝病。
J Ethnopharmacol. 2022 Aug 10;294:115333. doi: 10.1016/j.jep.2022.115333. Epub 2022 Apr 29.
7
Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.肠道微生物群和胆汁酸部分介导了成纤维细胞生长因子21对蛋氨酸-胆碱缺乏饮食诱导的非酒精性脂肪性肝病小鼠的改善作用。
Free Radic Biol Med. 2023 Feb 1;195:199-218. doi: 10.1016/j.freeradbiomed.2022.12.087. Epub 2022 Dec 28.
8
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease.胆汁酸及其受体:非酒精性脂肪性肝病的生物学与药物研发
Acta Pharmacol Sin. 2022 May;43(5):1103-1119. doi: 10.1038/s41401-022-00880-z. Epub 2022 Feb 25.
9
Bile acids and microbes in metabolic disease.胆汁酸与代谢疾病相关的微生物。
World J Gastroenterol. 2022 Dec 28;28(48):6846-6866. doi: 10.3748/wjg.v28.i48.6846.
10
Circulating Bile Acids as Biomarkers for Disease Diagnosis and Prevention.循环胆汁酸作为疾病诊断和预防的生物标志物
J Clin Endocrinol Metab. 2023 Jan 17;108(2):251-270. doi: 10.1210/clinem/dgac659.

引用本文的文献

1
Global research trends on the interaction between gut microbiome and bile acids: a bibliometric and visualized analysis.肠道微生物群与胆汁酸相互作用的全球研究趋势:文献计量学与可视化分析
Front Cell Infect Microbiol. 2025 Jul 29;15:1616995. doi: 10.3389/fcimb.2025.1616995. eCollection 2025.
2
Oncohepatology: Navigating liver injury in the era of modern cancer therapy.肿瘤肝脏病学:现代癌症治疗时代的肝脏损伤应对策略
World J Hepatol. 2025 Jun 27;17(6):106932. doi: 10.4254/wjh.v17.i6.106932.
3
Interplay between the gut microbiota, its metabolites and carcinogens.

本文引用的文献

1
Inulin fibre promotes microbiota-derived bile acids and type 2 inflammation.菊粉纤维促进肠道微生物衍生胆汁酸和 2 型炎症。
Nature. 2022 Nov;611(7936):578-584. doi: 10.1038/s41586-022-05380-y. Epub 2022 Nov 2.
2
Human gut bacteria produce Τ17-modulating bile acid metabolites.人体肠道细菌产生调节 T17 型细胞的胆汁酸代谢物。
Nature. 2022 Mar;603(7903):907-912. doi: 10.1038/s41586-022-04480-z. Epub 2022 Mar 16.
3
Bile Acid-Microbiome Interaction Promotes Gastric Carcinogenesis.胆汁酸与微生物群的相互作用促进胃癌发生。
肠道微生物群、其代谢产物与致癌物之间的相互作用。
Clin Transl Oncol. 2025 May 13. doi: 10.1007/s12094-025-03920-2.
4
Design and application of graphene oxide-based molecularly imprinted covalent organic framework for simultaneous and precise recognition of bile acid metabolites.基于氧化石墨烯的分子印迹共价有机框架用于同时精确识别胆汁酸代谢物的设计与应用
Mikrochim Acta. 2025 Mar 31;192(4):271. doi: 10.1007/s00604-025-07120-1.
5
Imbalance of Bile Acids Metabolism Mediated by Gut Microbiota Contributed to Metabolic Disorders in Diabetic Model Mice.肠道微生物群介导的胆汁酸代谢失衡促成糖尿病模型小鼠的代谢紊乱。
Biology (Basel). 2025 Mar 13;14(3):291. doi: 10.3390/biology14030291.
6
Bile acids as a key target: traditional Chinese medicine for precision management of insulin resistance in type 2 diabetes mellitus through the gut microbiota-bile acids axis.胆汁酸作为关键靶点:通过肠道微生物群-胆汁酸轴精准管理2型糖尿病胰岛素抵抗的中药研究
Front Endocrinol (Lausanne). 2024 Dec 10;15:1481270. doi: 10.3389/fendo.2024.1481270. eCollection 2024.
7
Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes.靶向肠道微生物群预防和管理 2 型糖尿病。
Nutrients. 2024 Nov 19;16(22):3951. doi: 10.3390/nu16223951.
8
Silybin Meglumine Mitigates CCl-Induced Liver Fibrosis and Bile Acid Metabolism Alterations.水飞蓟宾葡甲胺减轻四氯化碳诱导的肝纤维化和胆汁酸代谢改变。
Metabolites. 2024 Oct 17;14(10):556. doi: 10.3390/metabo14100556.
9
Retrospective Longitudinal Observational Study on the Long-Term Effects of Sodium-Glucose Cotransporter-2 Inhibitors on the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetic Japanese Patients.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病日本患者代谢功能障碍相关脂肪性肝病发生发展的长期影响的回顾性纵向观察研究
J Clin Med. 2024 Aug 21;13(16):4929. doi: 10.3390/jcm13164929.
10
NAFLD/MASLD and the Gut-Liver Axis: From Pathogenesis to Treatment Options.非酒精性脂肪性肝病/代谢功能障碍相关脂肪性肝病与肠-肝轴:从发病机制到治疗选择
Metabolites. 2024 Jun 28;14(7):366. doi: 10.3390/metabo14070366.
Adv Sci (Weinh). 2022 May;9(16):e2200263. doi: 10.1002/advs.202200263. Epub 2022 Mar 14.
4
Defective humoral immunity disrupts bile acid homeostasis which promotes inflammatory disease of the small bowel.体液免疫缺陷破坏胆汁酸稳态,从而促进小肠炎症性疾病。
Nat Commun. 2022 Jan 26;13(1):525. doi: 10.1038/s41467-022-28126-w.
5
Altered bile acid glycine : taurine ratio in the progression of chronic liver disease.慢性肝病进展中胆汁酸甘氨酸:牛磺酸比值的改变。
J Gastroenterol Hepatol. 2022 Jan;37(1):208-215. doi: 10.1111/jgh.15709. Epub 2021 Nov 2.
6
Effects of tauroursodeoxycholic acid on glucose homeostasis: Potential binding of this bile acid with the insulin receptor.牛磺熊去氧胆酸对葡萄糖稳态的影响:这种胆酸与胰岛素受体的潜在结合。
Life Sci. 2021 Nov 15;285:120020. doi: 10.1016/j.lfs.2021.120020. Epub 2021 Oct 5.
7
Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.肠道微生物群的耗竭通过法尼醇X受体(FXR)信号通路的丧失加剧胆汁淤积性肝损伤。
Nat Metab. 2021 Sep;3(9):1228-1241. doi: 10.1038/s42255-021-00452-1. Epub 2021 Sep 22.
8
Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis.肠道微生物群调控肠上皮细胞 P-糖蛋白以维持内稳态。
Microbiome. 2021 Sep 7;9(1):183. doi: 10.1186/s40168-021-01137-3.
9
Serum bile acids in cystic fibrosis patients - glycodeoxycholic acid as a potential marker of liver disease.囊性纤维化患者的血清胆汁酸 - 甘氨脱氧胆酸作为肝病的潜在标志物。
Dig Liver Dis. 2022 Jan;54(1):111-117. doi: 10.1016/j.dld.2021.06.034. Epub 2021 Jul 22.
10
Association of Elevated Maternal Serum Total Bile Acids With Low Birth Weight and Intrauterine Fetal Growth Restriction.血清总胆汁酸水平升高与低出生体重及胎儿宫内生长受限的相关性研究。
JAMA Netw Open. 2021 Jul 1;4(7):e2117409. doi: 10.1001/jamanetworkopen.2021.17409.